Literature DB >> 15218950

Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies.

Corinne Bouvier1, Patrice Roll, Benoit Quilichini, Philippe Metellus, Arlette Calisti, Sophie Gilles, Olivier Chinot, Frederic Fina, Pierre M Martin, Dominique Figarella-Branger.   

Abstract

Among diffuse gliomas, oligodendrogliomas may account for 25% of cases. They have a better prognosis and chemosensitivity as compared to astrocytomas. Genetic studies have shown a correlation between oligodendrocyte phenotype and presence of 1p/19q deletions. In addition, these deletions are of prognostic value. The aim of the present study was to describe a new method to detect 1p/19q deletions when little tumoral material is available (stereotactic biopsies (SBs)). Since smears (cytological preparations) are routinely done for intraoperative diagnosis of gliomas, we have searched for 1p/19q deletions by FISH in a series of 30 patients with a glioma. In 14 cases, loss of heterozygosity (LOH) analysis was also performed in order to validate our method. We found that FISH analysis on frozen smears was a simple, rapid and reliable method to detect 1p/19q deletions and a good concordance was found with LOH data (85%). The main advantages of FISH analysis on frozen smears are the following. First, it requires little material and can be easily done in the case of SBs. Second, it has a higher sensitivity than LOH especially in infiltrative areas of gliomas. Third, it allows detection of a codeletion 1p/19q in a single tumor cell. In contrast, LOH analysis is easier to interpret and can detect smaller and partial deletion whose pronostic significance remains to be defined. In conclusion, these two techniques can be used to investigate 1p/19q status in gliomas. The appropriate choice of one or other of these two techniques will depend on the specific questions that need to be answered.

Entities:  

Mesh:

Year:  2004        PMID: 15218950     DOI: 10.1023/b:neon.0000027758.10286.c1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  [The "smears" technique for the extemporaneous examination: diagnostic contribution to neurosurgical pathology].

Authors:  F Beuvon; P Varlet; C Fallet-Bianco; C Daumas-Duport
Journal:  Ann Pathol       Date:  2000-10       Impact factor: 0.407

2.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Authors:  J S Smith; A Perry; T J Borell; H K Lee; J O'Fallon; S M Hosek; D Kimmel; A Yates; P C Burger; B W Scheithauer; R B Jenkins
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

Review 3.  Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications.

Authors:  J S Smith; R B Jenkins
Journal:  Front Biosci       Date:  2000-01-01

4.  Detection of p16 gene deletions in gliomas: a comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR.

Authors:  A Perry; T Nobori; N Ru; K Anderl; T J Borell; G Mohapatra; B G Feuerstein; R B Jenkins; D A Carson
Journal:  J Neuropathol Exp Neurol       Date:  1997-09       Impact factor: 3.685

5.  Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression.

Authors:  K Hoang-Xuan; J He; S Huguet; K Mokhtari; Y Marie; M Kujas; P Leuraud; L Capelle; J Y Delattre; J Poirier; P Broët; M Sanson
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

6.  Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction.

Authors:  S Kösel; M B Graeber
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Authors:  S H Bigner; M R Matthews; B K Rasheed; R N Wiltshire; H S Friedman; A H Friedman; T T Stenzel; D M Dawes; R E McLendon; D D Bigner
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

8.  Impact of genotype and morphology on the prognosis of glioblastoma.

Authors:  Matthias C Schmidt; Sven Antweiler; Nina Urban; Wolf Mueller; A Kuklik; Birgit Meyer-Puttlitz; Otmar D Wiestler; David N Louis; Rolf Fimmers; Andreas von Deimling
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

9.  Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.

Authors:  Johan M Kros; P Zheng; Winand N M Dinjens; Janneke C Alers
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

10.  Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors.

Authors:  Toshihiko Iuchi; Hiroki Namba; Yasuo Iwadate; Tomotane Shishikura; Hajime Kageyama; Yoko Nakamura; Miki Ohira; Akira Yamaura; Katsunobu Osato; Shigeru Sakiyama; Akira Nakagawara
Journal:  Genes Chromosomes Cancer       Date:  2002-10       Impact factor: 5.006

View more
  6 in total

1.  Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Authors:  Irena Srebotnik-Kirbiš; Clara Limbäck-Stokin
Journal:  J Neurooncol       Date:  2016-07-12       Impact factor: 4.130

Review 2.  Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

Authors:  Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Sebastian Brandner; Luke Vale; Julian Pt Higgins; Kathreena M Kurian
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

3.  IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients.

Authors:  Philippe Metellus; Carole Colin; David Taieb; Eric Guedj; Isabelle Nanni-Metellus; Andre Maues de Paula; Cécile Colavolpe; Stephane Fuentes; Henry Dufour; Marylin Barrie; Olivier Chinot; L'houcine Ouafik; Dominique Figarella-Branger
Journal:  J Neurooncol       Date:  2011-06-05       Impact factor: 4.506

4.  Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system.

Authors:  Dominique Figarella-Branger; Corinne Bouvier; André Maues de Paula; Karima Mokhtari; Carole Colin; Anderson Loundou; Olivier Chinot; Philippe Metellus
Journal:  J Neurooncol       Date:  2012-08-14       Impact factor: 4.506

Review 5.  Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.

Authors:  Sebastian Brandner; Alexandra McAleenan; Hayley E Jones; Ashleigh Kernohan; Tomos Robinson; Lena Schmidt; Sarah Dawson; Claire Kelly; Emmelyn Spencer Leal; Claire L Faulkner; Abigail Palmer; Christopher Wragg; Sarah Jefferies; Luke Vale; Julian P T Higgins; Kathreena M Kurian
Journal:  Neuropathol Appl Neurobiol       Date:  2022-03-03       Impact factor: 6.250

6.  ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas.

Authors:  Céline Duval; Marie de Tayrac; François Sanschagrin; Karine Michaud; Peter Vincent Gould; Stéphan Saikali
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.